Literature DB >> 18618666

Uric acid in Parkinson's disease.

Ilana Schlesinger1, Naomi Schlesinger.   

Abstract

Recent studies have provided evidence that uric acid may play a role in the development and progression of Parkinson's disease (PD). Uric acid is a natural antioxidant that may reduce oxidative stress, a mechanism thought to play a role in the pathogenesis of PD. Higher levels of serum urate (SU) may have a neuroprotective effect. High SU levels reduced the risk of developing PD and correlated with slower PD progression. Among PD patients SU levels were lower as compared with controls. The manipulation of SU levels holds promise in the treatment of PD. It is possible that a high purine diet in patients with PD may slow progression of the disease. Milk and meat consumption as well as exercise modify the risk of developing PD possibly through their influence on SU levels. In this article, we review the association between PD and SU levels and its implication on the management of PD. (c) 2007 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18618666     DOI: 10.1002/mds.22139

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  42 in total

Review 1.  Biochemical premotor biomarkers for Parkinson's disease.

Authors:  Brit Mollenhauer; Jing Zhang
Journal:  Mov Disord       Date:  2012-04-15       Impact factor: 10.338

2.  Uric acid: a danger signal from the RNA world that may have a role in the epidemic of obesity, metabolic syndrome, and cardiorenal disease: evolutionary considerations.

Authors:  Richard J Johnson; Miguel A Lanaspa; Eric A Gaucher
Journal:  Semin Nephrol       Date:  2011-09       Impact factor: 5.299

Review 3.  ABCG transporters and disease.

Authors:  Owen M Woodward; Anna Köttgen; Michael Köttgen
Journal:  FEBS J       Date:  2011-06-13       Impact factor: 5.542

4.  CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's disease.

Authors:  Peter LeWitt; Lonni Schultz; Peggy Auinger; Mei Lu
Journal:  Brain Res       Date:  2011-07-01       Impact factor: 3.252

5.  The risk of Parkinson disease associated with urate in a community-based cohort of older adults.

Authors:  S Jain; T G Ton; R M Boudreau; M Yang; E L Thacker; S Studenski; W T Longstreth; E S Strotmeyer; A B Newman
Journal:  Neuroepidemiology       Date:  2011-06-16       Impact factor: 3.282

6.  Crystal arthritis: New recommendations highlight the need for more research.

Authors:  Naomi Schlesinger
Journal:  Nat Rev Rheumatol       Date:  2016-09-09       Impact factor: 20.543

7.  Impact of serum uric acid, albumin and their interaction on Parkinson's disease.

Authors:  Lijun Wang; Wei Hu; Jun Wang; Fangfang Fang; Guanliang Cheng; Yuzhang Jiang; Hang Xiao; Qi Wan
Journal:  Neurol Sci       Date:  2016-11-22       Impact factor: 3.307

8.  Effect of serum uric acid on cognition in patients with idiopathic REM sleep behavior disorder.

Authors:  Xudong Li; Shuhong Jia; Zhi Zhou; Yi Jin; Xiangfei Zhang; Chunlei Hou; Wenjing Zheng; Pei Rong; Jinsong Jiao
Journal:  J Neural Transm (Vienna)       Date:  2018-10-03       Impact factor: 3.575

Review 9.  Potential influences of complementary therapy on motor and non-motor complications in Parkinson's disease.

Authors:  Theresa A Zesiewicz; Marian L Evatt
Journal:  CNS Drugs       Date:  2009-10       Impact factor: 5.749

10.  Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study.

Authors:  Maria Teresa Pellecchia; Riccardo Savastano; Marcello Moccia; Marina Picillo; Pietro Siano; Roberto Erro; Annamaria Vallelunga; Marianna Amboni; Carmine Vitale; Gabriella Santangelo; Paolo Barone
Journal:  J Neural Transm (Vienna)       Date:  2016-09-28       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.